Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CITIGROUP INC Capital/Financing Update 2015

Sep 17, 2015

14792_rns_2015-09-17_6541f380-3bfd-4228-a75a-b614cbe8b267.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

Citigroup Inc. Pricing Sheet No. 2015-CMTNG0663 dated September 15, 2015 relating to Amended and Restated Preliminary Pricing Supplement No. 2015-CMTNG0663 dated September 1, 2015 Registration Statement No. 333-192302 Filed Pursuant to Rule 433

56,822 Trigger Jump Securities Based on Shares of the Energy Select Sector SPDR ® Fund Due September 20, 2018 Principal at Risk Securities

PRICING TERMS—SEPTEMBER 15, 2015 — Underlying shares: Shares of the Energy Select Sector SPDR ® Fund (NYSE Arca symbol: “XLE”) (the “underlying share issuer” or “ETF”)
Aggregate stated principal amount: $568,220
Stated principal amount: $10 per security
Pricing date: September 15, 2015
Issue date: September 18, 2015
Valuation date: September 17, 2018, subject to postponement if such date is not a scheduled trading day or if certain market disruption events occur
Maturity date: September 20, 2018
Payment at maturity: For each $10 stated principal amount security you hold
at maturity: ▪ If the final
share price is greater than or equal to the initial share price: $10 + the upside payment ▪ If the final
share price is less than the initial share price but greater than or equal to the trigger price: $10 ▪ If the final
share price is less than the trigger price: $10 × the share performance factor If the final share price is less than the trigger
price, your payment at maturity will be less, and possibly significantly less, than $8.00 per security. You should not invest
in the securities unless you are willing and able to bear the risk of losing a significant portion and up to all of your investment.
Initial share price: $63.52, the closing price of the underlying shares on the pricing date
Final share price: The closing price of the underlying shares on the valuation date
Upside payment: $3.55 per security (equivalent to an upside return at maturity of 35.50% of the stated principal amount). You will receive the upside payment only if the final share price is greater than or equal to the initial share price.
Share performance factor: The final share price divided by the initial share price
Trigger price: $50.816, 80.00% of the initial share price
Listing: The securities will not be listed on any securities exchange.
CUSIP / ISIN: 17323Q684 / US17323Q6843
Underwriter: Citigroup Global Markets Inc. (“CGMI”), an affiliate of the issuer, acting as principal
Underwriting fee and issue price: Issue price (1)(2) Underwriting fee Proceeds to issuer (2)
Per security: $10.00 $0.25 (2) $9.70
$0.05 (3)
Total: $568,220.00 $17,046.60 $551,173.40

(1) On the pricing date, the estimated value of the securities is $9.278 per security, which is less than the issue price. The estimated value of the securities is based on CGMI’s proprietary pricing models and our internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time after issuance. See “Valuation of the Securities” in the related preliminary pricing supplement.

(2) CGMI, an affiliate of Citigroup Inc. and the underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of $0.30 for each $10 security sold in this offering. Certain selected dealers, including Morgan Stanley Wealth Management and their financial advisors, will collectively receive from CGMI a fixed selling concession of $0.25 for each $10 security they sell. Additionally, it is possible that CGMI and its affiliates may profit from hedging activity related to this offering, even if the value of the securities declines. See “Use of Proceeds and Hedging” in the accompanying prospectus.

(3) Reflects a structuring fee payable to Morgan Stanley Wealth Management by CGMI of $0.05 for each security.

You should read this document together with the related preliminary pricing supplement and the other following documents, each of which can be accessed via the hyperlinks below:

Amended and Restated Preliminary Pricing Supplement dated September 1, 2015

Product Supplement No. EA-02-03 dated November 13, 2013 Prospectus Supplement and Prospectus each dated November 13, 2013

The securities are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of, or guaranteed by, a bank.

SPDR ® is a registered trademark of S&P Dow Jones Indices LLC (“S&P Dow Jones”) and has been licensed for use by Citigroup Inc. and its affiliates. The securities are not sponsored, endorsed, sold or promoted by S&P Dow Jones. S&P Dow Jones makes no representations or warranties to the owners of the securities or any member of the public regarding the advisability of investing in the securities. S&P Dow Jones has no obligation or liability in connection with the operation, marketing, trading or sale of the securities.

Citigroup Inc. has filed a registration statement (including a related preliminary pricing supplement and the accompanying product supplement, prospectus supplement and prospectus) with the Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. You should read the related preliminary pricing supplement and the accompanying product supplement, prospectus supplement and prospectus in that registration statement (File No. 333-192302) and the other documents Citigroup Inc. has filed with the SEC for more complete information about Citigroup Inc. and this offering. You may get these documents for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, you can request the related preliminary pricing supplement and the accompanying product supplement, prospectus supplement and prospectus by calling toll-free 1-800-831-9146.